The Vaginal Microbiota over an 8- to 10-Year Period in a Cohort of HIV-Infected and HIV-Uninfected Women

Background We identified predominant vaginal microbiota communities, changes over time, and how this varied by HIV status and other factors in a cohort of 64 women. Methods Bacterial DNA was extracted from reposited cervicovaginal lavage samples collected annually over an 8–10 year period from Chicago Women’s Interagency HIV Study participants: 22 HIV-negative, 22 HIV-positive with stable infection, 20 HIV-positive with progressive infection. The vaginal microbiota was defined by pyrosequencing of the V1/V2 region of the 16S rRNA gene. Scheduled visits included Bacterial vaginsosis (BV) screening; clinically detected cases were referred for treatment. Hierarchical clustering identified bacterial community state types (CST). Multinomial mixed effects modeling determined trends over time in CST, by HIV status and other factors. Results The median follow-up time was 8.1 years (range 5.5–15.3). Six CSTs were identified. The mean relative abundance (RA) of Lactobacillus spp. by CST (with median number of bacterial taxa) was: CST-1–25.7% (10), CST-2–27.1% (11), CST-3–34.6% (9), CST-4–46.8% (9), CST-5–57.9% (4), CST-6–69.4% (2). The two CSTs representing the highest RA of Lactobacillus and lowest diversity increased with each additional year of follow-up (CST-5, adjusted odds ratio (aOR) = 1.62 [95% CI: 1.34–1.94]; CST-6, aOR = 1.57 [95 CI: 1.31–1.89]), while the two CSTs representing lowest RA of Lactobacillus and higher diversity decreased with each additional year (CST-1, aOR = 0.89 [95% CI: 0.80–1.00]; CST-2, aOR = 0.86 [95% CI: 0.75–0.99]). There was no association between HIV status and CST at baseline or over time. CSTs representing lower RA of Lactobacillus were associated with current cigarette smoking. Conclusions The vaginal microbial community significantly improved over time in this cohort of women with HIV and at high risk for HIV who had regular detection and treatment referral for BV.

[1]  James R. Cole,et al.  The Ribosomal Database Project (RDP-II): sequences and tools for high-throughput rRNA analysis , 2004, Nucleic Acids Res..

[2]  R. K. Hanson,et al.  High Rates of Sexual Behavior in the General Population: Correlates and Predictors , 2006, Archives of sexual behavior.

[3]  P. Gajer,et al.  Association between cigarette smoking and the vaginal microbiota: a pilot study , 2014, BMC Infectious Diseases.

[4]  A. Rutherford,et al.  Influence of bacterial vaginosis on conception and miscarriage in the first trimester: cohort study , 1999, BMJ.

[5]  P. Gajer,et al.  Vaginal microbiome of reproductive-age women , 2010, Proceedings of the National Academy of Sciences.

[6]  C. Morrison,et al.  Bacterial Vaginosis and Vaginal Yeast, But Not Vaginal Cleansing, Increase HIV-1 Acquisition in African Women , 2008, Journal of acquired immune deficiency syndromes.

[7]  Jeanne M. Marrazzo,et al.  Bacterial Communities in Women with Bacterial Vaginosis: High Resolution Phylogenetic Analyses Reveal Relationships of Microbiota to Clinical Criteria , 2012, PloS one.

[8]  Rob Knight,et al.  UCHIME improves sensitivity and speed of chimera detection , 2011, Bioinform..

[9]  K. Holmes,et al.  Selective differential human blood bilayer media for isolation of Gardnerella (Haemophilus) vaginalis , 1982, Journal of clinical microbiology.

[10]  J. Kendrick,et al.  The Prevalence of Bacterial Vaginosis in the United States, 2001–2004; Associations With Symptoms, Sexual Behaviors, and Reproductive Health , 2007, Sexually transmitted diseases.

[11]  Joseph Feldman,et al.  The Women's Interagency HIV Study , 1998 .

[12]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[13]  R. Desmond,et al.  Natural history of asymptomatic bacterial vaginosis in a high-risk group of women. , 2007, Sexually transmitted diseases.

[14]  Zaid Abdo,et al.  Temporal Dynamics of the Human Vaginal Microbiota , 2012, Science Translational Medicine.

[15]  William A. Walters,et al.  Experimental and analytical tools for studying the human microbiome , 2011, Nature Reviews Genetics.

[16]  A. Landay,et al.  Bacterial vaginosis-associated microflora isolated from the female genital tract activates HIV-1 expression. , 1999, Journal of acquired immune deficiency syndromes.

[17]  M. Graham,et al.  Molecular Definition of Vaginal Microbiota in East African Commercial Sex Workers , 2011, Applied and Environmental Microbiology.

[18]  K. Holmes,et al.  Nonspecific vaginitis: Diagnostic criteria and microbial and epidemiologic associations , 1983 .

[19]  D. Costagliola,et al.  Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIV , 2009, AIDS.

[20]  J. Hocking,et al.  Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  Mary Frances Cotch,et al.  Association between Bacterial Vaginosis and Preterm Delivery of a Low-Birth-Weight Infant , 1995 .

[22]  S. Garland,et al.  Efficacy of Oral Metronidazole with Vaginal Clindamycin or Vaginal Probiotic for Bacterial Vaginosis: Randomised Placebo-Controlled Double-Blind Trial , 2012, PloS one.

[23]  R. Ness,et al.  A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease. , 2005, American journal of epidemiology.

[24]  M. Krohn,et al.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  L. Tao,et al.  Induction of vaginal Lactobacillus phages by the cigarette smoke chemical benzo[a]pyrene diol epoxide. , 2000, Mutation research.

[26]  J. Schwebke,et al.  Prevalence of Gardnerella vaginalis among women with lactobacillus-predominant vaginal flora , 2013, Sexually Transmitted Infections.

[27]  C. Wachihi,et al.  Bacterial vaginosis, HIV serostatus and T-cell subset distribution in a cohort of East African commercial sex workers: retrospective analysis , 2012, AIDS.

[28]  N. Balakrishna,et al.  Cervicovaginal Inflammatory Cytokines and Sphingomyelinase in Women With and Without Bacterial Vaginosis , 2012, The American journal of the medical sciences.

[29]  J. Sobel,et al.  Longitudinal Analysis of Bacterial Vaginosis: Findings From the HIV Epidemiology Research Study , 2001, Obstetrics and gynecology.

[30]  A. Adimora,et al.  Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies , 2008, AIDS.

[31]  R. Desmond,et al.  A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent the acquisition of sexually transmitted diseases. , 2007, American journal of obstetrics and gynecology.

[32]  K. Holmes,et al.  Prevalence of hydrogen peroxide-producing Lactobacillus species in normal women and women with bacterial vaginosis , 1989, Journal of clinical microbiology.

[33]  D R Hoover,et al.  Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV , 1998, AIDS.

[34]  P. Mirmonsef,et al.  The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract. , 2012, Current HIV research.

[35]  M. Krohn,et al.  Cervical anti-inflammatory cytokine concentrations among first-trimester pregnant smokers. , 2005, American journal of obstetrics and gynecology.

[36]  J. Malina.  [Microbiology of bacterial vaginosis]. , 1995, Ceska gynekologie.

[37]  William A. Walters,et al.  QIIME allows analysis of high-throughput community sequencing data , 2010, Nature Methods.

[38]  Connie Celum,et al.  Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples , 2012, PLoS medicine.

[39]  J. Marrazzo,et al.  Targeted PCR for Detection of Vaginal Bacteria Associated with Bacterial Vaginosis , 2007, Journal of Clinical Microbiology.

[40]  Gary King,et al.  Matching as Nonparametric Preprocessing for Reducing Model Dependence in Parametric Causal Inference , 2007, Political Analysis.

[41]  P. Mirmonsef,et al.  Short‐Chain Fatty Acids Induce Pro‐Inflammatory Cytokine Production Alone and in Combination with Toll‐Like Receptor Ligands , 2012, American journal of reproductive immunology.

[42]  A. Telenti,et al.  Host and Viral Genetic Correlates of Clinical Definitions of HIV-1 Disease Progression , 2010, PloS one.

[43]  L. Meyn,et al.  A Delicate Balance: Risk Factors for Acquisition of Bacterial Vaginosis Include Sexual Activity, Absence of Hydrogen Peroxide-Producing Lactobacilli, Black Race, and Positive Herpes Simplex Virus Type 2 Serology , 2008, Sexually transmitted diseases.

[44]  Masoumeh Sikaroodi,et al.  Comparison of the diversity of the vaginal microbiota in HIV-infected and HIV-uninfected women with or without bacterial vaginosis. , 2008, The Journal of infectious diseases.

[45]  N. Hessol,et al.  Retention and attendance of women enrolled in a large prospective study of HIV-1 in the United States. , 2009, Journal of women's health.

[46]  M. Young,et al.  The Women's Interagency HIV Study: an Observational Cohort Brings Clinical Sciences to the Bench , 2005, Clinical Diagnostic Laboratory Immunology.

[47]  D. Taylor-Robinson,et al.  Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage , 1994, BMJ.

[48]  R. Greenblatt,et al.  The Occurrence of Vaginal Infections Among HIV-Infected and High-Risk HIV-Uninfected Women: Longitudinal Findings of the Women's Interagency HIV Study , 2006, Journal of acquired immune deficiency syndromes.

[49]  R. Veazey,et al.  Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. , 2010, AIDS research and human retroviruses.

[50]  M. Krohn,et al.  Lower Genital Tract Infection and Endometritis: Insight Into Subclinical Pelvic Inflammatory Disease , 2002, Obstetrics and gynecology.

[51]  C. Morrison,et al.  Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission , 2013, AIDS.

[52]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[53]  D. Raoult,et al.  Molecular quantification of Gardnerella vaginalis and Atopobium vaginae loads to predict bacterial vaginosis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  R. Edelman,et al.  "Association between Bacterial Vaginosis and Preterm Delivery of a Low- birth-weight Infant." , 1996 .

[55]  J. French,et al.  Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: results of a controlled trial of topical clindamycin cream. , 1994, American journal of obstetrics and gynecology.

[56]  D. Fredricks.  Molecular methods to describe the spectrum and dynamics of the vaginal microbiota. , 2011, Anaerobe.